Industries > Pharma > Liquid Biopsy Market Report 2020-2030
Liquid Biopsy Market Report 2020-2030
Forecasts by Product (Instruments, Kits & Reagents, Services), by Sample Type (Blood Samples, Urine Samples, Others), by Biomarker (Circulating Tumour Cell (CTC), Circulating Tumour DNA (ctDNA), Exosomes, Others), by Cancer Type (Breast Cancer, Colorectal Cancer, Liver Cancer, Lung Cancer, Prostate Cancer, Others), by End-user (Hospitals, Diagnostic Laboratories, Academic Institutions, Cancer Research Centres), by Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa), Plus Analysis of Leading Companies
The main drivers for the growth include technological advancements such as development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies. Moreover, rising number of pre-screening programs for cancer detection using liquid biopsy are expected to provide new market opportunities to the key players in the near future.
This Visiongain report covers the global liquid biopsy market, including analysis of the market by product type, biomarker type, sample type, cancer type, end user and national markets for liquid biopsy products. We aim to provide a comprehensive and critical analysis of the market, assessing the market’s potential from a variety of viewpoints. We examine the opportunities and challenges that exist within the market, as well as the major commercial trends. We also analyses the market prospects for different segments and provide an overview of the research and development in this sector.
This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.
To access the data contained in this document please email contactus@visiongain.com
Liquid Biopsy Market Dynamics:
• Increasing Prevalence of Cancer
• Rising Ageing Population
• Rising Demand for Safe and Minimally Invasive Procedures
• Advantages of Liquid Biopsy and Cost Effectiveness
• Disparity in Reimbursements
• Strict Regulatory Environment
• Increasing involvement of global market players through collaborations/agreements
• Progress in the development of liquid biopsy tests
Liquid Biopsy Market Segmentation 2020-2030:
Segmentation by Product, 2020 – 2030 (USD Million)
• Instruments
• Kits & Reagents
• Services
Segmentation by Sample Type, 2020 – 2030 (USD Million)
• Blood Samples
• Urine Samples
• Others
Segmentation by Biomarker, 2020 – 2030 (USD Million)
• Circulating Tumour Cell (CTC)
• Circulating Tumour DNA (ctDNA)
• Exosomes
• Others
Segmentation by Cancer Type, 2020 – 2030 (USD Million)
• Breast Cancer
• Colorectal Cancer
• Liver Cancer
• Lung Cancer
• Prostate Cancer
• Others
Segmentation by End-User, 2020 – 2030 (USD Million)
• Hospitals
• Diagnostic Laboratories
• Academic Institutions
• Cancer Research Centres
Segmentation by Geography, 2020 – 2030 (USD Million)
• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Poland
• Rest of Europe
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Southeast Asia
• Rest of Asia Pacific
• Latin America
• Brazil
• Argentina
• Venezuela
• Mexico
• Rest of Latin America
• Middle East & Africa
• Turkey
• UAE
• South Africa
• Saudi Arabia
• Rest of Middle East & Africa
Liquid Biopsy Market: Top 10 Companies
• Menarini Silicon Biosystems, Inc.
• MDxHealth SA
• Biocept, Inc.
• Trovagene, Inc.
• Sysmex Inostics GmbH
• F. Hoffmann-La Roche AG
• Bio-Rad Laboratories, Inc.
• Guardant Health, Inc.
• Illumina, Inc.
• Myriad Genetics, Inc.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Liquid Biopsy Market Report 2020-2030: Forecasts by Product (Instruments, Kits & Reagents, Services), by Sample Type (Blood Samples, Urine Samples, Others), by Biomarker (Circulating Tumour Cell (CTC), Circulating Tumour DNA (ctDNA), Exosomes, Others), by Cancer Type (Breast Cancer, Colorectal Cancer, Liver Cancer, Lung Cancer, Prostate Cancer, Others), by End-user (Hospitals, Diagnostic Laboratories, Academic Institutions, Cancer Research Centres), by Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa), Plus Analysis of Leading Companies. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Global Liquid Biopsy Market Overview
1.2. Why You Should Read This Report
1.3. How This Report Delivers
1.4. Key Questions Answered by This Analytical Report
1.5. Who Is This Report For?
1.6. Methodology
1.6.1. Primary Research
1.6.2. Secondary Research
1.6.3. Market Evaluation & Forecasting Methodology
1.6.4. Market Size Estimation
1.7. Frequently Asked Questions (FAQ)
1.8. Associated Visiongain Reports
1.9. About Visiongain
2. Liquid Biopsy: Executive Summary
3. Liquid Biopsy Market Outlook
3.1. Introduction
3.2. Liquid Biopsy Industry: Drivers
3.2.1. Increasing Prevalence of Cancer
3.2.2. Rising Ageing Population
3.2.3. Rising Demand for Safe and Minimally Invasive Procedures
3.2.4. Advantages of Liquid Biopsy and Cost Effectiveness
3.3. Liquid Biopsy Industry: Restraints
3.3.1. Disparity in Reimbursements
3.3.2. Strict Regulatory Environment
3.4. Liquid Biopsy Industry Future Opportunities
3.4.1. Increasing involvement of global market players through collaborations/agreements
3.4.2. Progress in the development of liquid biopsy tests
3.5. Liquid Biopsy Industry: Regulatory Landscape
3.6. Liquid Biopsy Industry: Latest developments
3.6.1. Emergence of artificial intelligence technologies
3.6.2. Liquid biopsy is considered to be one of the most significant breakthrough treatments for cancer
3.6.3. Multi-Target Liquid Biopsy would be a novel clinical test to watch out in 2019
3.7. Liquid Biopsy Industry: PESTEL Analysis
3.7.1. Political
3.7.1.1. Regulatory Bodies
3.7.1.2. Insurance / Reimbursement:
3.7.2. Economic
3.7.3. Social
3.7.4. Environmental
3.7.5. Technological
3.7.5.1. Advent of New Technologies
3.7.5.2. Early Stage Diagnosis of Cancer with Liquid Biopsies
3.7.5.3. Improved Liquid Biopsy Techniques
3.7.5.4. Comparison with Tissue Sampling
3.7.5.5. Cost Reductions and Time Saving with Liquid Biopsies
3.7.6. Legal
3.7.6.1. Regulatory Science Challenge
3.7.6.2. FDA
3.7.6.3. Lawsuits and Litigations
3.8. Liquid Biopsy Industry: SWOT Analysis
3.8.1. Strength
3.8.2. Weakness
3.8.3. Opportunities
3.8.4. Threats
3.9. Liquid Biopsy Industry: Porter’s Five Forces Analysis
3.10. COVID-19 Impact on Liquid Biopsy Industry
4. Liquid Biopsy Market by Product
4.1. Liquid Biopsy Market Outlook by Product
4.2. Kits & Reagents
4.3. Services
5. Liquid Biopsy Market By Sample Type
5.1. Liquid Biopsy Market Outlook By Sample Type
5.2. Blood Samples
5.3. Urine Samples
5.4. Others
6. Liquid Biopsy Market By Biomarker
6.1. Liquid Biopsy Market Outlook By Biomarker
6.2. Circulating Tumour Cell (CTC)
6.3. Circulating Tumour DNA (ctDNA)
6.4. Exosomes
6.5. Others
7. Liquid Biopsy Market By Cancer Type
7.1. Liquid Biopsy Market Outlook By Cancer Type
7.2. Breast Cancer
7.3. Colorectal Cancer
7.4. Liver Cancer
7.5. Lung Cancer
7.6. Prostate Cancer
7.7. Other Cancers
8. Liquid Biopsy Market By End-User
8.1. Liquid Biopsy Market Outlook By End-User
8.2. Hospitals
8.3. Diagnostic Laboratories
8.4. Academic Institutions
8.5. Cancer Research Centres
9. Liquid Biopsy Market By Region
9.1. Liquid Biopsy Market Outlook By Region
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. UK
9.3.4. Italy
9.3.5. Spain
9.3.6. Russia
9.3.7. Poland
9.3.8. Rest of Europe
9.4. Asia Pacific
9.4.1. Japan
9.4.2. China
9.4.3. Australia
9.4.4. India
9.4.5. South Korea
9.4.6. Southeast Asia
9.4.7. Rest of APAC
9.5. Latin America
9.5.1. Brazil
9.5.2. Argentina
9.5.3. Venezuela
9.5.4. Mexico
9.5.5. Rest of Latin America
9.6. Middle East & Africa
9.6.1. Saudi Arabia
9.6.2. South Africa
9.6.3. Turkey
9.6.4. UAE
9.6.5. Rest of Middle East & Africa
10. Company Profiles
10.1. Competitive Landscape: Liquid Biopsy Market
10.2. Emerging Companies: Liquid Biopsy Market
10.3. Menarini Silicon Biosystems
10.3.1. Company Overview
10.3.2. Menarini Group: Financials 2015-2018
10.3.3. Menarini Silicon Biosystems Products
10.3.4. Recent News
10.4. MDxHealth SA
10.4.1. Company Overview
10.4.2. MDxHealth SA: Financials 2015-2019
10.4.3. MDxHealth SA Products
10.4.4. Recent News
10.5. Biocept
10.5.1. Company Overview
10.5.2. Biocept: Financials 2015-2019
10.5.3. Biocept Products
10.5.4. Recent News
10.6. Trovagene
10.6.1. Company Overview
10.6.2. Trovagene: Financials 2015-2019
10.6.3. Trovagene Products
10.6.4. Recent News
10.7. Sysmex Corp
10.7.1. Company Overview
10.7.2. Sysmex Corp: Financials 2015-2019
10.7.3. Sysmex Corp Products
10.7.4. Recent News
10.8. F. Hoffmann-La Roche AG
10.8.1. Company Overview
10.8.2. F. Hoffmann-La Roche AG: Financials 2015-2019
10.8.3. F. Hoffmann-La Roche AG Products
10.8.4. Recent News
10.9. Bio-Rad Laboratories
10.9.1. Company Overview
10.9.2. Bio-Rad Laboratories: Financials 2015-2019
10.9.3. Bio-Rad Laboratories Products
10.9.4. Recent News
10.10. Guardant Health
10.10.1. Company Overview
10.10.2. Guardant Health: Financials 2015-2019
10.10.3. Guardant Health Products
10.10.4. Recent News
10.11. Illumina
10.11.1. Company Overview
10.11.2. Illumina: Financials 2015-2019
10.11.3. Illumina Products
10.11.4. Recent News
10.12. Myriad Genetics
10.12.1. Company Overview
10.12.2. Myriad Genetics: Financials 2015-2019
10.12.3. Myriad Genetics Products
10.12.4. Recent News
10.13. Qiagen N.V.
10.13.1. Company Overview
10.13.2. Qiagen N.V.: Financials 2015-2019
10.13.3. Qiagen N.V. Products
10.13.4. Recent News
10.14. Lineage Cell Therapeutics
10.14.1. Company Overview
10.14.2. Lineage Cell Therapeutics: Financials 2015-2019
10.14.3. Lineage Cell Therapeutics Products
10.14.4. Recent News
10.15. Abbott
10.15.1. Company Overview
10.15.2. Abbott Laboratories: Financials 2015-2019
10.15.3. Abbott Laboratories Products
10.15.4. Recent News
10.16. Beckman Coulter (Danaher Corporation)
10.16.1. Company Overview
10.16.2. Danaher Corporation: Financials 2015-2019
10.16.3. Beckman Coulter Products
10.16.4. Recent News
10.17. Caris Life Sciences
10.17.1. Company Overview
10.17.2. Caris Life Sciences Products
10.18. OPKO Health
10.18.1. Company Overview
10.18.2. OPKO Health: Financials 2015-2019
10.18.3. OPKO Health Products
10.18.4. Recent News
10.19. Thermo Fisher Scientific
10.19.1. Company Overview
10.19.2. Thermo Fisher Scientific: Financials 2015-2019
10.19.3. Thermo Fisher Scientific Products
10.19.4. Recent News
10.20. Johnson & Johnson
10.20.1. Company Overview
10.20.2. Johnson & Johnson: Financials 2015-2019
10.20.3. Johnson & Johnson Products
10.20.4. Recent News
10.21. Exact Sciences Corporation
10.21.1. Company Overview
10.21.2. Exact Sciences Corporation: Financials 2015-2019
10.21.3. Exact Sciences Corporation Products
10.21.4. Recent News
10.22. Vermillion
10.22.1. Company Overview
10.22.2. Vermillion: Financials 2015-2019
10.22.3. Vermillion Products
10.22.4. Recent News
11. Conclusion & Recommendations
11.1. COVID-19 Impact
12. Glossary
Appendix A About Visiongain
Appendix B Visiongain report evaluation form
List of Tables
Table 1 Liquid Biopsy Market, 2020 – 2030 (USD Million)
Table 2 Liquid Biopsy Technologies for Screening and Early Detection
Table 3 Liquid Biopsy Market for Instruments, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 4 Liquid Biopsy Market for Instruments, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 5 Liquid Biopsy Market for Instruments, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 6 Liquid Biopsy Market for Instruments, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 7 Liquid Biopsy Market for Instruments, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 8 Liquid Biopsy Market for Kits & Reagents, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 9 Liquid Biopsy Market for Kits & Reagents, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 10 Liquid Biopsy Market for Kits & Reagents, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 11 Liquid Biopsy Market for Kits & Reagents, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 12 Liquid Biopsy Market for Kits & Reagents, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 13 Liquid Biopsy Market for Services, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 14 Liquid Biopsy Market for Services, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 15 Liquid Biopsy Market for Services, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 16 Liquid Biopsy Market for Services, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 17 Liquid Biopsy Market for Services, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 18 Liquid Biopsy Market for Blood Samples, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 19 Liquid Biopsy Market for Blood Samples, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 20 Liquid Biopsy Market for Blood Samples, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 21 Liquid Biopsy Market for Blood Samples, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 22 Liquid Biopsy Market for Blood Samples, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 23 Liquid Biopsy Market for Urine Samples, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 24 Liquid Biopsy Market for Urine Samples, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 25 Liquid Biopsy Market for Urine Samples, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 26 Liquid Biopsy Market for Urine Samples, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 27 Liquid Biopsy Market for Urine Samples, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 28 Liquid Biopsy Market for Other Samples, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 29 Liquid Biopsy Market for Other Samples, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 30 Liquid Biopsy Market for Other Samples, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 31 Liquid Biopsy Market for Other Samples, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 32 Liquid Biopsy Market for Other Samples, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 33 Liquid Biopsy Market for Circulating Tumour Cell (CTC), 2020-2030 (USD Mn, AGR %, CAGR %)
Table 34 Liquid Biopsy Market for Circulating Tumour Cell (CTC), 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 35 Liquid Biopsy Market for Circulating Tumour Cell (CTC), 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 36 Liquid Biopsy Market for Circulating Tumour Cell (CTC), 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 37 Liquid Biopsy Market for Circulating Tumour Cell (CTC), 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 38 Liquid Biopsy Market for Circulating Tumour DNA (ctDNA), 2020-2030 (USD Mn, AGR %, CAGR %)
Table 39 Liquid Biopsy Market for Circulating Tumour DNA (ctDNA), 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 40 Liquid Biopsy Market for Circulating Tumour DNA (ctDNA), 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 41 Liquid Biopsy Market for Circulating Tumour DNA (ctDNA), 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 42 Liquid Biopsy Market for Circulating Tumour DNA (ctDNA), 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 43 Liquid Biopsy Market for Exosomes, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 44 Liquid Biopsy Market for Exosomes, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 45 Liquid Biopsy Market for Exosomes, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 46 Liquid Biopsy Market for Exosomes, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 47 Liquid Biopsy Market for Exosomes, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 48 Liquid Biopsy Market for Other Biomarker, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 49 Liquid Biopsy Market for Other Biomarker, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 50 Liquid Biopsy Market for Other Biomarker, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 51 Liquid Biopsy Market for Other Biomarker, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 52 Liquid Biopsy Market for Other Biomarker, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 53 Liquid Biopsy Market for Breast Cancer, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 54 Liquid Biopsy Market for Breast Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 55 Liquid Biopsy Market for Breast Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 56 Liquid Biopsy Market for Breast Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 57 Liquid Biopsy Market for Breast Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 58 Liquid Biopsy Market for Colorectal Cancer, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 59 Liquid Biopsy Market for Colorectal Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 60 Liquid Biopsy Market for Colorectal Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 61 Liquid Biopsy Market for Colorectal Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 62 Liquid Biopsy Market for Colorectal Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 63 Liquid Biopsy Market for Liver Cancer, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 64 Liquid Biopsy Market for Liver Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 65 Liquid Biopsy Market for Liver Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 66 Liquid Biopsy Market for Liver Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 67 Liquid Biopsy Market for Liver Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 68 Liquid Biopsy Market for Lung Cancer, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 69 Liquid Biopsy Market for Lung Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 70 Liquid Biopsy Market for Lung Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 71 Liquid Biopsy Market for Lung Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 72 Liquid Biopsy Market for Lung Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 73 Liquid Biopsy Market for Prostate Cancer, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 74 Liquid Biopsy Market for Prostate Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 75 Liquid Biopsy Market for Prostate Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 76 Liquid Biopsy Market for Prostate Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 77 Liquid Biopsy Market for Prostate Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 78 Liquid Biopsy Market for Other Cancers, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 79 Liquid Biopsy Market for Other Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 80 Liquid Biopsy Market for Other Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 81 Liquid Biopsy Market for Other Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 82 Liquid Biopsy Market for Other Cancer, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 83 Liquid Biopsy Market for Hospitals, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 84 Liquid Biopsy Market for Hospitals, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 85 Liquid Biopsy Market for Hospitals, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 86 Liquid Biopsy Market for Hospitals, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 87 Liquid Biopsy Market for Hospitals, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 88 Liquid Biopsy Market for Diagnostic Laboratories, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 89 Liquid Biopsy Market for Diagnostic Laboratories, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 90 Liquid Biopsy Market for Diagnostic Laboratories, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 91 Liquid Biopsy Market for Diagnostic Laboratories, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 92 Liquid Biopsy Market for Diagnostic Laboratories, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 93 Liquid Biopsy Market for Academic Institutions, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 94 Liquid Biopsy Market for Academic Institutions, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 95 Liquid Biopsy Market for Academic Institutions, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 96 Liquid Biopsy Market for Academic Institutions, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 97 Liquid Biopsy Market for Academic Institutions, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 98 Liquid Biopsy Market for Cancer Research Centres, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 99 Liquid Biopsy Market for Cancer Research Centres, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 100 Liquid Biopsy Market for Cancer Research Centres, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 101 Liquid Biopsy Market for Cancer Research Centres, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 102 Liquid Biopsy Market for Cancer Research Centres, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 103 North America Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 104 North America Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 105 North America Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 106 North America Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 107 North America Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 108 North America Liquid Biopsy Market By Sample Type, 2020 – 2030 (USD Mn)
Table 109 North America Liquid Biopsy Market By Product, 2020 – 2030 (USD Mn)
Table 110 North America Liquid Biopsy Market By Biomarker, 2020 – 2030 (USD Mn)
Table 111 North America Liquid Biopsy Market By Cancer Type, 2020 – 2030 (USD Mn)
Table 112 North America Liquid Biopsy Market By End-User, 2020 – 2030 (USD Mn)
Table 113 U.S. Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 114 U.S. Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 115 U.S. Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 116 U.S. Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 117 U.S. Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 118 Canada Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 119 Canada Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 120 Canada Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 121 Canada Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 122 Canada Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 123 Europe Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 124 Europe Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 125 Europe Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 126 Europe Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 127 Europe Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 128 Europe Liquid Biopsy Market By Sample Type, 2020 – 2030 (USD Mn)
Table 129 Europe Liquid Biopsy Market By Product, 2020 – 2030 (USD Mn)
Table 130 Europe Liquid Biopsy Market By Biomarker, 2020 – 2030 (USD Mn)
Table 131 Europe Liquid Biopsy Market By Cancer Type, 2020 – 2030 (USD Mn)
Table 132 Europe Liquid Biopsy Market By End-User, 2020 – 2030 (USD Mn)
Table 133 Germany Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 134 Germany Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 135 Germany Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 136 Germany Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 137 Germany Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 138 France Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 139 France Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 140 France Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 141 France Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 142 France Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 143 UK Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 144 UK Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 145 UK Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 146 UK Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 147 UK Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 148 Italy Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 149 Italy Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 150 Italy Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 151 Italy Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 152 Italy Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 153 Spain Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 154 Spain Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 155 Spain Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 156 Spain Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 157 Spain Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 158 Russia Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 159 Russia Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 160 Russia Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 161 Russia Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 162 Russia Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 163 Poland Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 164 Poland Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 165 Poland Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 166 Poland Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 167 Poland Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 168 Rest of Europe Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 169 Rest of Europe Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 170 Rest of Europe Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 171 Rest of Europe Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 172 Rest of Europe Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 173 Asia Pacific Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 174 Asia Pacific Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 175 Asia Pacific Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 176 Asia Pacific Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 177 Asia Pacific Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 178 Asia Pacific Liquid Biopsy Market By Sample Type, 2020 – 2030 (USD Mn)
Table 179 Asia Pacific Liquid Biopsy Market By Product, 2020 – 2030 (USD Mn)
Table 180 Asia Pacific Liquid Biopsy Market By Biomarker, 2020 – 2030 (USD Mn)
Table 181 Asia Pacific Liquid Biopsy Market By Cancer Type, 2020 – 2030 (USD Mn)
Table 182 Asia Pacific Liquid Biopsy Market By End-User, 2020 – 2030 (USD Mn)
Table 183 Japan Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 184 Japan Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 185 Japan Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 186 Japan Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 187 Japan Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 188 China Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 189 China Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 190 China Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 191 China Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 192 China Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 193 Australia Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 194 Australia Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 195 Australia Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 196 Australia Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 197 Australia Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 198 India Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 199 India Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 200 India Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 201 India Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 202 India Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 203 South Korea Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 204 South Korea Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 205 South Korea Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 206 South Korea Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 207 South Korea Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 208 Southeast Asia Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 209 Southeast Asia Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 210 Southeast Asia Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 211 Southeast Asia Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 212 Southeast Asia Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 213 Rest of APAC Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 214 Rest of Asia Pacific Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 215 Rest of Asia Pacific Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 216 Rest of Asia Pacific Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 217 Rest of Asia Pacific Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 218 Latin America Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 219 Latin America Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 220 Latin America Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 221 Latin America Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 222 Latin America Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 223 Latin America Liquid Biopsy Market By Sample Type, 2020 – 2030 (USD Mn)
Table 224 Latin America Liquid Biopsy Market By Product, 2020 – 2030 (USD Mn)
Table 225 Latin America Liquid Biopsy Market By Biomarker, 2020 – 2030 (USD Mn)
Table 226 Latin America Liquid Biopsy Market By Cancer Type, 2020 – 2030 (USD Mn)
Table 227 Latin America Liquid Biopsy Market By End-User, 2020 – 2030 (USD Mn)
Table 228 Brazil Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 229 Brazil Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 230 Brazil Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 231 Brazil Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 232 Brazil Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 233 Argentina Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 234 Argentina Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 235 Argentina Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 236 Argentina Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 237 Argentina Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 238 Venezuela Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 239 Venezuela Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 240 Venezuela Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 241 Venezuela Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 242 Venezuela Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 243 Mexico Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 244 Mexico Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 245 Mexico Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 246 Mexico Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 247 Mexico Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 248 Rest of LA Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 249 Rest of Latin America Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 250 Rest of Latin America Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 251 Rest of Latin America Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 252 Rest of Latin America Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 253 Middle East & Africa Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 254 Middle East & Africa Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 255 Middle East & Africa Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 256 Middle East & Africa Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 257 Middle East & Africa Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 258 Middle East & Africa Liquid Biopsy Market By Sample Type, 2020 – 2030 (USD Mn)
Table 259 Middle East & Africa Liquid Biopsy Market By Product, 2020 – 2030 (USD Mn)
Table 260 Middle East & Africa Liquid Biopsy Market By Biomarker, 2020 – 2030 (USD Mn)
Table 261 Middle East & Africa Liquid Biopsy Market By Cancer Type, 2020 – 2030 (USD Mn)
Table 262 Middle East & Africa Liquid Biopsy Market By End-User, 2020 – 2030 (USD Mn)
Table 263 Saudi Arabia Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 264 Saudi Arabia Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 265 Saudi Arabia Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 266 Saudi Arabia Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 267 Saudi Arabia Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 268 South Africa Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 269 South Africa Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 270 South Africa Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 271 South Africa Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 272 South Africa Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 273 Turkey Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 274 Turkey Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 275 Turkey Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 276 Turkey Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 277 Turkey Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 278 UAE Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 279 UAE Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 280 UAE Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 281 UAE Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 282 UAE Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 283 Rest of MEA Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %)
Table 284 Rest of Middle East & Africa Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (V-Shaped Recovery)
Table 285 Rest of Middle East & Africa Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (U-Shaped Recovery)
Table 286 Rest of Middle East & Africa Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (L-Shaped Recovery)
Table 287 Rest of Middle East & Africa Liquid Biopsy Market, 2020-2030 (USD Mn, AGR %, CAGR %) (W-Shaped Recovery)
Table 288 Emerging Liquid Biopsy Companies
Table 289 Menarini Silicon Biosystems: Key Details 2020 (Headquarter, Founded, Employees, Company Type, Website, Business Segment)
Table 290 Menarini Silicon Biosystems: Products
Table 291 Menarini Silicon Biosystems: Recent Developments (Date, Type, Details)
Table 292 MDxHealth SA: Key Details 2020 (Headquarter, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 293 MDxHealth SA: Products
Table 294 MDxHealth SA: Recent Developments (Date, Type, Details)
Table 295 Biocept: Key Details 2020 (CEO, Headquarter, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 296 Biocept: Products
Table 297 Biocept: Recent Developments (Date, Type, Details)
Table 298 Trovagene: Key Details 2020 (Headquarter, Founded, No. of Employees, Company Type, Website, Technology)
Table 299 Trovagene: Products
Table 300 Trovagene: Recent Developments (Date, Type, Details)
Table 301 Sysmex Corporation: Key Details 2020 (Headquarter, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 302 Sysmex Corp: Products
Table 303 Sysmex Corp: Recent Developments (Date, Type, Details)
Table 304 F. Hoffmann-La Roche AG: Key Details 2020 (Headquarter, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 305 F. Hoffmann-La Roche AG: Products
Table 306 F. Hoffmann-La Roche AG: Recent Developments (Date, Type, Details)
Table 307 Bio-Rad Laboratories: Key Details 2020 (Headquarter, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 308 Bio-Rad Laboratories: Products
Table 309 Bio-Rad Laboratories: Recent Developments (Date, Type, Details)
Table 310 Guardant Health: Key Details 2020 (Headquarter, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 311 Guardant Health: Products
Table 312 Guardant Health: Recent Developments (Date, Type, Details)
Table 313 Illumina: Key Details 2020 (Headquarter, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 314 Illumina: Products
Table 315 Illumina: Recent Developments (Date, Type, Details)
Table 316 Myriad Genetics: Key Details 2020 (Headquarter, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 317 Myriad Genetics: Products
Table 318 Myriad Genetics: Recent Developments (Date, Type, Details)
Table 319 Qiagen N.V.: Key Details 2020 (Headquarter, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 320 Qiagen N.V.: Products
Table 321 Qiagen N.V.: Recent Developments (Date, Type, Details)
Table 322 Lineage Cell Therapeutics: Key Details 2020 (Headquarter, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 323 Lineage Cell Therapeutics: Products
Table 324 Lineage Cell Therapeutics: Recent Developments (Date, Type, Details)
Table 325 Abbott Laboratories: Key Details 2020 (Headquarter, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 326 Abbott Laboratories: Products
Table 327 Abbott Laboratories: Recent Developments (Date, Type, Details)
Table 328 Beckman Coulter: Key Details 2020 (Headquarter, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 329 Beckman Coulter: Products
Table 330 Beckman Coulter: Recent Developments (Date, Type, Details)
Table 331 Caris Life Sciences: Key Details 2020 (Headquarter, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 332 Caris Life Sciences: Products
Table 333 OPKO Health: Key Details 2020 (Headquarter, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 334 OPKO Health: Products
Table 335 OPKO Health: Recent Developments (Date, Type, Details)
Table 336 Thermo Fisher Scientific: Key Details 2020 (Headquarter, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 337 Thermo Fisher Scientific: Products
Table 338 Thermo Fisher Scientific: Recent Developments (Date, Type, Details)
Table 339 Johnson & Johnson: Key Details 2020 (Headquarter, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 340 Johnson & Johnson: Products
Table 341 Johnson & Johnson: Recent Developments (Date, Type, Details)
Table 342 Exact Sciences Corporation: Key Details 2020 (Headquarter, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 343 Exact Sciences Corporation: Products
Table 344 Exact Sciences Corporation: Recent Developments (Date, Type, Details)
Table 345 Vermillion: Key Details 2020 (Headquarter, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 346 Vermillion: Products
Table 347 Vermillion: Recent Developments (Date, Type, Details)
List of Figures
FIG.1 Market Segmentation & Scope
FIG.2 Liquid Biopsy Industry: Drivers
FIG.3 Worldwide Cancer Death by Age, 2018 (%)
FIG.4 Share of population with cancer, 2018 (%)
FIG.5 Ageing Population Estimates 2010 - 2050
FIG.6 Liquid Biopsy Industry: Restraints
FIG.7 Liquid Biopsy Industry: Opportunities
FIG.8 Timeline of FDA Approvals and Breakthrough Device Designations
FIG.9 Liquid Biopsy Industry: Latest developments
FIG.10 Global Liquid Biopsy Market Size By Product, 2020 – 2030 (USD Million, AGR %)
FIG.11 Global Liquid Biopsy Market Size By Product, 2020 – 2030 (USD Million, AGR %) (V-Shaped Recovery)
FIG.12 Global Liquid Biopsy Market Size By Product, 2020 – 2030 (USD Million, AGR %) (U-Shaped Recovery)
FIG.13 Global Liquid Biopsy Market Size By Product, 2020 – 2030 (USD Million, AGR %) (L-Shaped Recovery)
FIG.14 Global Liquid Biopsy Market Size By Product, 2020 – 2030 (USD Million, AGR %) (W-Shaped Recovery)
FIG.15 Global Liquid Biopsy Market Share By Product, 2020, 2025, 2030 (%)
FIG.16 Liquid Biopsy for Instruments Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.17 Liquid Biopsy for Instruments Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.18 Liquid Biopsy for Instruments Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.19 Liquid Biopsy for Instruments Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.20 Liquid Biopsy for Instruments Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.21 Liquid Biopsy for Kits & Reagents Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.22 Liquid Biopsy for Kits & Reagents Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.23 Liquid Biopsy for Kits & Reagents Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.24 Liquid Biopsy for Kits & Reagents Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.25 Liquid Biopsy for Kits & Reagents Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.26 Liquid Biopsy for Services Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.27 Liquid Biopsy for Services Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.28 Liquid Biopsy for Services Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.29 Liquid Biopsy for Services Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.30 Liquid Biopsy for Services Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.31 Global Liquid Biopsy Market Size By Sample Type, 2020 – 2030 (USD Million, AGR %)
FIG.32 Global Liquid Biopsy Market Size By Sample Type, 2020 – 2030 (USD Million, AGR %) (V-Shaped Recovery)
FIG.33 Global Liquid Biopsy Market Size By Sample Type, 2020 – 2030 (USD Million, AGR %) (U-Shaped Recovery)
FIG.34 Global Liquid Biopsy Market Size By Sample Type, 2020 – 2030 (USD Million, AGR %) (L-Shaped Recovery)
FIG.35 Global Liquid Biopsy Market Size By Sample Type, 2020 – 2030 (USD Million, AGR %) (W-Shaped Recovery)
FIG.36 Global Liquid Biopsy Market Share By Sample Type, 2020, 2025, 2030 (%)
FIG.37 Liquid Biopsy for Blood Samples Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.38 Liquid Biopsy for Blood Samples Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.39 Liquid Biopsy for Blood Samples Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.40 Liquid Biopsy for Blood Samples Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.41 Liquid Biopsy for Blood Samples Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.42 Liquid Biopsy for Urine Samples Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.43 Liquid Biopsy for Urine Samples Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.44 Liquid Biopsy for Urine Samples Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.45 Liquid Biopsy for Urine Samples Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.46 Liquid Biopsy for Urine Samples Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.47 Liquid Biopsy for Other Samples Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.48 Liquid Biopsy for Other Samples Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.49 Liquid Biopsy for Other Samples Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.50 Liquid Biopsy for Other Samples Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.51 Liquid Biopsy for Other Samples Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.52 Global Liquid Biopsy Market Size By Biomarker, 2020 – 2030 (USD Million, AGR %)
FIG.53 Global Liquid Biopsy Market Size By Biomarker, 2020 – 2030 (USD Million, AGR %) (V-Shaped Recovery)
FIG.54 Global Liquid Biopsy Market Size By Biomarker, 2020 – 2030 (USD Million, AGR %) (U-Shaped Recovery)
FIG.55 Global Liquid Biopsy Market Size By Biomarker, 2020 – 2030 (USD Million, AGR %) (L-Shaped Recovery)
FIG.56 Global Liquid Biopsy Market Size By Biomarker, 2020 – 2030 (USD Million, AGR %) (W-Shaped Recovery)
FIG.57 Global Liquid Biopsy Market Share By Biomarker, 2020, 2025, 2030 (%)
FIG.58 Liquid Biopsy for Circulating Tumour Cell (CTC) Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.59 Liquid Biopsy for Circulating Tumour Cell (CTC) Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.60 Liquid Biopsy for Circulating Tumour Cell (CTC) Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.61 Liquid Biopsy for Circulating Tumour Cell (CTC) Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.62 Liquid Biopsy for Circulating Tumour Cell (CTC) Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.63 Liquid Biopsy for Circulating Tumour DNA (ctDNA) Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.64 Liquid Biopsy for Circulating Tumour DNA (ctDNA) Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.65 Liquid Biopsy for Circulating Tumour DNA (ctDNA) Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.66 Liquid Biopsy for Circulating Tumour DNA (ctDNA) Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.67 Liquid Biopsy for Circulating Tumour DNA (ctDNA) Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.68 Liquid Biopsy for Exosomes Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.69 Liquid Biopsy for Exosomes Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.70 Liquid Biopsy for Exosomes Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.71 Liquid Biopsy for Exosomes Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.72 Liquid Biopsy for Exosomes Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.73 Liquid Biopsy for Other Biomarker Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.74 Liquid Biopsy for Other Biomarker Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.75 Liquid Biopsy for Other Biomarker Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.76 Liquid Biopsy for Other Biomarker Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.77 Liquid Biopsy for Other Biomarker Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.78 Global Liquid Biopsy Market Size By Cancer Type, 2020 – 2030 (USD Million, AGR %)
FIG.79 Global Liquid Biopsy Market Size By Cancer Type, 2020 – 2030 (USD Million, AGR %) (V-Shaped Recovery)
FIG.80 Global Liquid Biopsy Market Size By Cancer Type, 2020 – 2030 (USD Million, AGR %) (U-Shaped Recovery)
FIG.81 Global Liquid Biopsy Market Size By Cancer Type, 2020 – 2030 (USD Million, AGR %) (L-Shaped Recovery)
FIG.82 Global Liquid Biopsy Market Size By Cancer Type, 2020 – 2030 (USD Million, AGR %) (W-Shaped Recovery)
FIG.83 Global Liquid Biopsy Market Share By Cancer Type, 2020, 2025, 2030 (%)
FIG.84 Liquid Biopsy for Breast Cancer Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.85 Liquid Biopsy for Breast Cancer Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.86 Liquid Biopsy for Breast Cancer Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.87 Liquid Biopsy for Breast Cancer Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.88 Liquid Biopsy for Breast Cancer Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.89 Liquid Biopsy for Colorectal Cancer Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.90 Liquid Biopsy for Colorectal Cancer Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.91 Liquid Biopsy for Colorectal Cancer Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.92 Liquid Biopsy for Colorectal Cancer Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.93 Liquid Biopsy for Colorectal Cancer Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.94 Liquid Biopsy for Liver Cancer Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.95 Liquid Biopsy for Liver Cancer Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.96 Liquid Biopsy for Liver Cancer Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.97 Liquid Biopsy for Liver Cancer Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.98 Liquid Biopsy for Liver Cancer Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.99 Liquid Biopsy for Lung Cancer Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.100 Liquid Biopsy for Lung Cancer Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.101 Liquid Biopsy for Lung Cancer Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.102 Liquid Biopsy for Lung Cancer Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.103 Liquid Biopsy for Lung Cancer Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.104 Liquid Biopsy for Prostate Cancer Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.105 Liquid Biopsy for Prostate Cancer Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.106 Liquid Biopsy for Prostate Cancer Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.107 Liquid Biopsy for Prostate Cancer Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.108 Liquid Biopsy for Prostate Cancer Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.109 Liquid Biopsy for Other Cancers Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.110 Liquid Biopsy for Other Cancer Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.111 Liquid Biopsy for Other Cancer Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.112 Liquid Biopsy for Other Cancer Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.113 Liquid Biopsy for Other Cancer Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.114 Global Liquid Biopsy Market Size By End-User, 2020 – 2030 (USD Million, AGR %)
FIG.115 Global Liquid Biopsy Market Size By End-User, 2020 – 2030 (USD Million, AGR %) (V-Shaped Recovery)
FIG.116 Global Liquid Biopsy Market Size By End-User, 2020 – 2030 (USD Million, AGR %) (U-Shaped Recovery)
FIG.117 Global Liquid Biopsy Market Size By End-User, 2020 – 2030 (USD Million, AGR %) (L-Shaped Recovery)
FIG.118 Global Liquid Biopsy Market Size By End-User, 2020 – 2030 (USD Million, AGR %) (W-Shaped Recovery)
FIG.119 Global Liquid Biopsy Market Share By End-User, 2020, 2025, 2030 (%)
FIG.120 Liquid Biopsy for Hospitals Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.121 Liquid Biopsy for Hospitals Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.122 Liquid Biopsy for Hospitals Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.123 Liquid Biopsy for Hospitals Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.124 Liquid Biopsy for Hospitals Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.125 Liquid Biopsy for Diagnostic Laboratories Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.126 Liquid Biopsy for Diagnostic Laboratories Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.127 Liquid Biopsy for Diagnostic Laboratories Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.128 Liquid Biopsy for Diagnostic Laboratories Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.129 Liquid Biopsy for Diagnostic Laboratories Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.130 Liquid Biopsy for Academic Institutions Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.131 Liquid Biopsy for Academic Institutions Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.132 Liquid Biopsy for Academic Institutions Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.133 Liquid Biopsy for Academic Institutions Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.134 Liquid Biopsy for Academic Institutions Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.135 Liquid Biopsy for Cancer Research Centres Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.136 Liquid Biopsy for Cancer Research Centres Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.137 Liquid Biopsy for Cancer Research Centres Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.138 Liquid Biopsy for Cancer Research Centres Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.139 Liquid Biopsy for Cancer Research Centres Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.140 Global Liquid Biopsy Market Size By Region, 2020 – 2030 (USD Million, AGR %)
FIG.141 Global Liquid Biopsy Market Size By Region, 2020 – 2030 (USD Million, AGR %) (V-Shaped Recovery)
FIG.142 Global Liquid Biopsy Market Size By Region, 2020 – 2030 (USD Million, AGR %) (U-Shaped Recovery)
FIG.143 Global Liquid Biopsy Market Size By Region, 2020 – 2030 (USD Million, AGR %) (L-Shaped Recovery)
FIG.144 Global Liquid Biopsy Market Size By Region, 2020 – 2030 (USD Million, AGR %) (W-Shaped Recovery)
FIG.145 Global Liquid Biopsy Market Share By Region, 2020, 2025, 2030 (%)
FIG.146 North America Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.147 North America Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.148 North America Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.149 North America Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.150 North America Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.151 North America Liquid Biopsy Market Share By Country, 2020, 2025, 2030 (%)
FIG.152 U.S. Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.153 U.S. Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.154 U.S. Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.155 U.S. Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.156 U.S. Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.157 Canada Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.158 Canada Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.159 Canada Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.160 Canada Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.161 Canada Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.162 Europe Liquid Biopsy Market Share By Country, 2020, 2025, 2030 (%)
FIG.163 Europe Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.164 Europe Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.165 Europe Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.166 Europe Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.167 Europe Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.168 Germany Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.169 Germany Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.170 Germany Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.171 Germany Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.172 Germany Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.173 France Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.174 France Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.175 France Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.176 France Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.177 France Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.178 UK Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.179 UK Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.180 UK Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.181 UK Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.182 UK Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.183 Italy Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.184 Italy Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.185 Italy Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.186 Italy Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.187 Italy Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.188 Spain Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.189 Spain Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.190 Spain Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.191 Spain Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.192 Spain Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.193 Russia Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.194 Russia Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.195 Russia Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.196 Russia Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.197 Russia Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.198 Poland Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.199 Poland Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.200 Poland Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.201 Poland Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.202 Poland Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.203 Rest of Europe Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.204 Rest of Europe Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.205 Rest of Europe Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.206 Rest of Europe Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.207 Rest of Europe Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.208 Asia Pacific Liquid Biopsy Market Share By Country, 2020, 2025, 2030 (%)
FIG.209 Asia Pacific Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.210 Asia Pacific Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.211 Asia Pacific Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.212 Asia Pacific Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.213 Asia Pacific Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.214 Japan Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.215 Japan Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.216 Japan Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.217 Japan Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.218 Japan Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.219 China Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.220 China Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.221 China Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.222 China Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.223 China Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.224 Australia Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.225 Australia Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.226 Australia Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.227 Australia Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.228 Australia Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.229 India Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.230 India Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.231 India Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.232 India Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.233 India Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.234 Korean Developers of Liquid Biopsy Technology
FIG.235 South Korea Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.236 South Korea Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.237 South Korea Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.238 South Korea Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.239 South Korea Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.240 Southeast Asia Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.241 Southeast Asia Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.242 Southeast Asia Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.243 Southeast Asia Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.244 Southeast Asia Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.245 Rest of APAC Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.246 Rest of Asia Pacific Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.247 Rest of Asia Pacific Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.248 Rest of Asia Pacific Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.249 Rest of Asia Pacific Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.250 Latin America Liquid Biopsy Market Share By Country, 2020, 2025, 2030 (%)
FIG.251 Latin America Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.252 Latin America Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.253 Latin America Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.254 Latin America Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.255 Latin America Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.256 Brazil Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.257 Brazil Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.258 Brazil Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.259 Brazil Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.260 Brazil Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.261 Argentina Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.262 Argentina Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.263 Argentina Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.264 Argentina Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.265 Argentina Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.266 Venezuela Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.267 Venezuela Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.268 Venezuela Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.269 Venezuela Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.270 Venezuela Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.271 Mexico Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.272 Number of cancer deaths in Mexico in 2018, by cancer type
FIG.273 Mexico Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.274 Mexico Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.275 Mexico Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.276 Mexico Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.277 Rest of LA Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.278 Rest of Latin America Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.279 Rest of Latin America Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.280 Rest of Latin America Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.281 Rest of Latin America Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.282 Middle East & Africa Liquid Biopsy Market Share By Country, 2020, 2025, 2030 (%)
FIG.283 Middle East & Africa Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.284 Middle East & Africa Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.285 Middle East & Africa Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.286 Middle East & Africa Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.287 Middle East & Africa Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.288 Saudi Arabia Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.289 Saudi Arabia Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.290 Saudi Arabia Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.291 Saudi Arabia Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.292 Saudi Arabia Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.293 South Africa Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.294 South Africa Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.295 South Africa Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.296 South Africa Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.297 South Africa Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.298 Turkey Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.299 Turkey Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.300 Turkey Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.301 Turkey Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.302 Turkey Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.303 UAE Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.304 UAE Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.305 UAE Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.306 UAE Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.307 UAE Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.308 Rest of MEA Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %)
FIG.309 Rest of Middle East & Africa Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (V-Shaped Recovery)
FIG.310 Rest of Middle East & Africa Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (U-Shaped Recovery)
FIG.311 Rest of Middle East & Africa Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (L-Shaped Recovery)
FIG.312 Rest of Middle East & Africa Liquid Biopsy Market Value Forecast, 2020 – 2030 (USD Mn, AGR %) (W-Shaped Recovery)
FIG.313 Top Companies in Liquid Biopsy Market
FIG.314 Liquid Biopsy Market: Company Market Positioning
FIG.315 Menarini Group: Financials, 2015-2018 (US$ million, AGR %)
FIG.316 MDxHealth SA: Financials, 2015-2019 (US$ million, AGR %)
FIG.317 Biocept: Financials, 2015-2019 (US$ thousand, AGR %)
FIG.318 Trovagene: Financials, 2015-2019 (US$ thousand, AGR %)
FIG.319 Sysmex Corp: Financials, 2015-2019 (US$ million, AGR %)
FIG.320 Sysmex Corp: Business Segment, 2019 (%)
FIG.321 Sysmex Corp: Regional Sales, 2019 (%)
FIG.322 F. Hoffmann-La Roche AG: Financials, 2015-2019 (US$ thousand, AGR %)
FIG.323 F. Hoffmann-La Roche AG: Business Segment, 2019 (%)
FIG.324 F. Hoffmann-La Roche AG: Pharmaceuticals Division – Sales by Therapeutic Area, 2019 (%)
FIG.325 F. Hoffmann-La Roche AG: Oncology Division – Sales by Product, 2019 (%)
FIG.326 Bio-Rad Laboratories : Financials, 2015-2019 (US$ million, AGR %)
FIG.327 Bio-Rad Laboratories: Business Segment, 2019 (%)
FIG.328 Bio-Rad Laboratories: Regional Sales, 2019 (%)
FIG.329 Guardant Health: Financials, 2015-2019 (US$ million, AGR %)
FIG.330 Guardant Health: Business Segment, 2019 (%)
FIG.331 Illumina: Financials, 2015-2019 (US$ million, AGR %)
FIG.332 Illumina: Business Segment, 2019 (%)
FIG.333 Illumina: Regional Sales, 2019 (%)
FIG.334 Myriad Genetics: Financials, 2015-2019 (US$ million, AGR %)
FIG.335 Myriad Genetics: Business Segment, 2019 (%)
FIG.336 Qiagen N.V.: Financials, 2015-2019 (US$ million, AGR %)
FIG.337 Qiagen N.V.: Business Segment, 2019 (%)
FIG.338 Qiagen N.V.: Regional Sales, 2019 (%)
FIG.339 Lineage Cell Therapeutics: Financials, 2015-2019 (US$ million, AGR %)
FIG.340 Abbott Laboratories: Financials, 2015-2019 (US$ million, AGR %)
FIG.341 Abbott: Business Segment, 2019 (%)
FIG.342 Abbott: Regional Sales, 2019 (%)
FIG.343 Danaher Corporation: Financials, 2015-2019 (US$ million, AGR %)
FIG.344 Danaher Corporation: Business Segment, 2019 (%)
FIG.345 Danaher Corporation: Regional Sales, 2019 (%)
FIG.346 OPKO Health : Financials, 2015-2019 (US$ million, AGR %)
FIG.347 OPKO Health: Business Segment, 2019 (%)
FIG.348 OPKO Health: Regional Sales, 2019 (%)
FIG.349 Thermo Fisher Scientific: Financials, 2015-2019 (US$ thousand, AGR %)
FIG.350 Thermo Fisher Scientific: Business Segment, 2019 (%)
FIG.351 Johnson & Johnson: Financials, 2015-2019 (US$ million, AGR %)
FIG.352 Johnson & Johnson: Business Segment, 2019 (%)
FIG.353 Johnson & Johnson: Regional Sales, 2019 (%)
FIG.354 Exact Sciences Corporation: Financials, 2015-2019 (US$ million, AGR %)
FIG.355 Exact Sciences Corporation: Business Segment, 2019 (%)
FIG.356 Vermillion: Financials, 2015-2019 (US$ thousand, AGR %)
FIG.357 Vermillion: Business Segment, 2019 (%)
Abbott
Beckman Coulter (Danaher Corporation)
Bio-Rad Laboratories, Inc.
Caris Life Sciences
Exact Sciences Corporation
F. Hoffmann-La Roche AG
Guardant Health, Inc.
Illumina, Inc.
Johnson & Johnson
Lineage Cell Therapeutics
MDxHealth SA, Biocept, Inc.
Menarini Silicon Biosystems, Inc.
Myriad Genetics, Inc.
OPKO Health, Inc.
Qiagen N.V.
Sysmex Inostics GmbH
Thermo Fisher Scientific Inc.
Trovagene, Inc.
Vermillion
Download sample pages
Complete the form below to download your free sample pages for Liquid Biopsy Market Report 2020-2030Related reports
-
Global Precision Cancer Diagnostic Tests Market Forecasts 2019-2029
The global precision cancer diagnostics tests market was estimated at $3.94 bn in 2018 and is expected to grow at...Full DetailsPublished: 06 June 2019 -
Global Cancer Immunotherapy Market Forecast 2019-2029
The world cancer immunotherapy market is expected to grow at a CAGR of 11.4% in the second half of the...Full DetailsPublished: 21 January 2019 -
Global Diagnostic Imaging Market Forecast 2019-2029
The global diagnostic imaging market is estimated to have reached $24.1bn in 2018. Ultrasound Imaging Systems segment held the largest...Full DetailsPublished: 20 September 2019 -
Global Immunochemistry Reagents, Analyzers and Test Kits Market 2019-2029
The global immunochemistry reagents, analyzers and test kits market is estimated to have reached $23bn in 2018 and is expected...
Full DetailsPublished: 30 September 2019 -
Checkpoint Inhibitors for Anti-Cancer Treatment Market 2019-2029
The global checkpoint inhibitors for anti-cancer treatment market is estimated to have reached $11.43 bn in 2018 and is expected...
Full DetailsPublished: 28 May 2019
Download sample pages
Complete the form below to download your free sample pages for Liquid Biopsy Market Report 2020-2030Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: jamie.roberts@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Jamie Roberts stating your chosen report title to jamie.roberts@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email jamie.roberts@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Drug Delivery Technologies Market Report 2024-2034
The global Drug Delivery Technologies market is estimated at US$1,729.6 billion in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period 2024-2034.
23 April 2024
Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034
The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.
18 April 2024
Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034
The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.
17 April 2024
Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034
The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.
12 April 2024
